At the news
? BEARISHIMPACT 6/10 S-3 filed Mar 31, 2026 at 21:50 ET
Oncolytics Biotech filed a shelf registration (S-3) to offer up to $250 million in securities, including common stock, preferred stock, warrants, purchase contracts, and units. This filing replaces a prior registration and carries forward $139 million in unsold securities. The shelf allows the company to raise capital opportunistically over time, signaling potential future dilution.
- Filed S-3 shelf registration for up to $250 million in securities
- Includes common stock, preferred stock, warrants, purchase contracts, and units
- Carries forward $139 million in unsold securities from a prior registration
- Market cap is $91 million, meaning the offering could result in over 170% dilution if fully utilized
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access